Advanced search
Publication Cover
Leukemia & Lymphoma Volume 48, 2007 - Issue 4
Submit an article Journal homepage
137
Views
42
CrossRef citations to date
0
Altmetric
Original

Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET

Bernd Kasper Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, D-69120, HeidelbergCorrespondence[email protected]
,
Gerlinde Egerer Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, D-69120, Heidelberg
,
Martina Gronkowski Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, D-69120, Heidelberg
,
Sabine Haufe Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, D-69120, Heidelberg
,
Thomas Lehnert Department of Surgery, Klinikum Bremen-Mitte, D-28205, Bremen
,
Michael Eisenhut Department of Radiopharmaceutical Chemistry, German Cancer Research Center, Heidelberg
,
Gunhild Mechtersheimer Department of Pathology, University of Heidelberg, Im Neuenheimer Feld 220/221, D-69120, Heidelberg
,
Anthony D. Ho Department of Internal Medicine V, University of Heidelberg, Im Neuenheimer Feld 410, D-69120, Heidelberg
&
Uwe Haberkorn Department of Nuclear Medicine, University of Heidelberg, Im Neuenheimer Feld 400, D-69120, Heidelberg
 show all
Pages 746-753 | Received 06 Sep 2006, Accepted 09 Nov 2006, Published online: 01 Jul 2009

Citations (42)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Martin Hutchings. (2009) PET imaging in lymphoma. Expert Review of Hematology 2:3, pages 261-276.
Read now
KA Kurdziel, G Ravizzini, BY Croft, JL Tatum, PL Choyke & H Kobayashi. (2008) The evolving role of nuclear molecular imaging in cancer. Expert Opinion on Medical Diagnostics 2:7, pages 829-842.
Read now
Rodney J. Hicks. (2007) The SUV and FLT PET: A tasty alphabet soup or a dog's breakfast?. Leukemia & Lymphoma 48:4, pages 649-652.
Read now

Articles from other publishers (39)

Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2020. Nuclear Oncology. Nuclear Oncology 1 45 .
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2022. Nuclear Oncology. Nuclear Oncology 431 474 .
Arif Sheikh, Shazia Fatima, Zain Khurshid & Zaheer Chiragh. 2022. Nuclear Medicine and Immunology. Nuclear Medicine and Immunology 359 432 .
Rodney J. Hicks. (2021) Molecular imaging with FLT: a case of Cassandra’s curse?. European Journal of Nuclear Medicine and Molecular Imaging 48:9, pages 2687-2689.
Crossref
Andrea Gallamini, Bruce Cheson & Martin Hutchings. 2020. Hodgkin Lymphoma. Hodgkin Lymphoma 113 143 .
Lucia Zanoni, Alessandro Broccoli, Alessandro Lambertini, Cinzia Pellegrini, Vittorio Stefoni, Filippo Lodi, Cristina Fonti, Cristina Nanni, Pier Luigi Zinzani & Stefano Fanti. (2019) Role of 18F-FLT PET/CT in suspected recurrent or residual lymphoma: final results of a pilot prospective trial. European Journal of Nuclear Medicine and Molecular Imaging 46:8, pages 1661-1671.
Crossref
Paola Anna Erba, Martina Sollini, Roberto Boni & Sara Galimberti. 2019. Nuclear Medicine Textbook. Nuclear Medicine Textbook 655 705 .
Sue C. Kaste, Scott E. Snyder, Monika L. Metzger, John T. Sandlund, Scott C. Howard, Matthew Krasin & Barry L. Shulkin. (2017) Comparison of 11 C-Methionine and 18 F-FDG PET/CT for Staging and Follow-up of Pediatric Lymphoma . Journal of Nuclear Medicine 58:3, pages 419-424.
Crossref
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2017. Nuclear Oncology. Nuclear Oncology 353 393 .
Martin Hutchings, Annika Loft & Tarec Christoffer El-Galaly. 2016. PET Scan in Hodgkin Lymphoma. PET Scan in Hodgkin Lymphoma 1 13 .
Lucia Zanoni, Andreas K. Buck & Ken Herrmann. 2016. Oncological PET/CT with Histological Confirmation. Oncological PET/CT with Histological Confirmation 65 76 .
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2016. Nuclear Oncology. Nuclear Oncology 1 42 .
Tarec Christoffer El-Galaly & Martin Hutchings. 2015. Non-Hodgkin Lymphoma. Non-Hodgkin Lymphoma 125 146 .
Andrea Gallamini, Martin Hutchings & Anna Borra. 2015. Hodgkin Lymphoma. Hodgkin Lymphoma 107 130 .
Anna Maffione, Sotirios Chondrogiannis, Adriano Marcolongo & Domenico Rubello. 2014. Imaging for Plastic Surgery. Imaging for Plastic Surgery 71 88 .
Esther Mena, Maria Liza Lindenberg, Baris I. Turkbey, Joanna Shih, Jean Logan, Stephen Adler, Karen Wong, Wyndham Wilson, Peter L. Choyke & Karen A. Kurdziel. (2014) A Pilot Study of the Value of 18F-Fluoro-Deoxy-Thymidine PET/CT in Predicting Viable Lymphoma in Residual 18F-FDG Avid Masses After Completion of Therapy. Clinical Nuclear Medicine 39:10, pages 874-881.
Crossref
D K Woolf, M Beresford, S P Li, M Dowsett, B Sanghera, W L Wong, L Sonoda, S Detre, V Amin, M-L Ah-See, D Miles & A Makris. (2014) Evaluation of FLT-PET-CT as an imaging biomarker of proliferation in primary breast cancer. British Journal of Cancer 110:12, pages 2847-2854.
Crossref
Hyewon Lee, Seok-ki Kim, Yong-il Kim, Tae Sung Kim, Se Hun Kang, Weon Seo Park, Tak Yun & Hyeon-Seok Eom. (2014) Early Determination of Prognosis by Interim 3′-Deoxy-3′- 18 F-Fluorothymidine PET in Patients with Non-Hodgkin Lymphoma . Journal of Nuclear Medicine 55:2, pages 216-222.
Crossref
Hui Wang, Bo Liu, Jiahe Tian, Baixuan Xu, Jinming Zhang, Baolin Qu & Yingmao Chen. (2013) Evaluation of 18F-FDG and 18F-FLT for monitoring therapeutic responses of colorectal cancer cells to radiotherapy. European Journal of Radiology 82:9, pages e484-e491.
Crossref
Matt Vanderhoek, Scott B. Perlman & Robert Jeraj. (2013) Impact of Different Standardized Uptake Value Measures on PET-Based Quantification of Treatment Response. Journal of Nuclear Medicine 54:8, pages 1188-1194.
Crossref
Giampaolo Tomasi & Eric O. Aboagye. (2013) Introduction to the analysis of PET data in oncology. Journal of Pharmacokinetics and Pharmacodynamics 40:4, pages 419-436.
Crossref
Hiroshi Hoshikawa, Terushige Mori, Takehito Kishino, Yuka Yamamoto, Ryuhei Inamoto, Kosuke Akiyama, Nozomu Mori & Yoshihiro Nishiyama. (2013) Changes in 18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography imaging in patients with head and neck cancer treated with chemoradiotherapy. Annals of Nuclear Medicine 27:4, pages 363-370.
Crossref
Francesco Bertagna, Giorgio Biasiotto & Raffaele Giubbini. (2013) The role of F-18-fluorothymidine PET in oncology. Clinical and Translational Imaging 1:2, pages 77-97.
Crossref
Charles Lin, Aravind Ravi Kumar, Jacqui Keller, Peter O’Rourke, David McFarlane, Raymond Gwynne, Lizbeth Kenny, Nicole Buddle, Jarad Martin, Brett Hughes & Paul Thomas. (2013) 18F-fluoro-L-thymidine Positron Emission Tomography for Mucosal Head and Neck Squamous Cell Carcinoma Treated with Definitive Chemoradiation: A Pilot Study of Nodal Assessment and Tracer Safety. ISRN Molecular Imaging 2013, pages 1-7.
Crossref
Heather A. Jacene & Richard L. Wahl. 2013. Nuclear Oncology. Nuclear Oncology 153 187 .
Giampaolo Tomasi & Lula Rosso. (2012) PET imaging: implications for the future of therapy monitoring with PET/CT in oncology. Current Opinion in Pharmacology 12:5, pages 569-575.
Crossref
Matthias R. Benz, Johannes Czernin, Martin S. Allen‐Auerbach, Sarah M. Dry, Piriya Sutthiruangwong, Claudio Spick, Caius Radu, Wolfgang A. Weber, William D. Tap & Fritz C. Eilber. (2011) 3′‐deoxy‐3′‐[ 18 F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma . Cancer 118:12, pages 3135-3144.
Crossref
Matt Vanderhoek, Scott B. Perlman & Robert Jeraj. (2012) Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response. Journal of Nuclear Medicine 53:1, pages 4-11.
Crossref
Lale Kostakoglu. (2012) Novel PET Radiotracers for Potential Use in Management of Lymphoma. PET Clinics 7:1, pages 83-117.
Crossref
H. von Euler & S. Eriksson. (2010) Comparative aspects of the proliferation marker thymidine kinase 1 in human and canine tumour diseases. Veterinary and Comparative Oncology 9:1, pages 1-15.
Crossref
Martin Hutchings & Andrea Gallamini. 2011. Hodgkin Lymphoma. Hodgkin Lymphoma 77 95 .
Tara Barwick, Badreddine Bencherif, James M. Mountz & Norbert Avril. (2009) Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation. Nuclear Medicine Communications 30:12, pages 908-917.
Crossref
Andreas K. Buck, Ken Herrmann, Changxian Shen, Tobias Dechow, Markus Schwaiger & Hans-Jürgen Wester. (2009) Molecular imaging of proliferation in vivo: Positron emission tomography with [18F]fluorothymidine. Methods 48:2, pages 205-215.
Crossref
Mark P.S. Dunphy & Jason S. Lewis. (2009) Radiopharmaceuticals in Preclinical and Clinical Development for Monitoring of Therapy with PET. Journal of Nuclear Medicine 50:Suppl 1, pages 106S-121S.
Crossref
Gregory Ravizzini, Baris Turkbey, Karen Kurdziel & Peter L. Choyke. (2009) New horizons in prostate cancer imaging. European Journal of Radiology 70:2, pages 212-226.
Crossref
Adrianus J. de Langen, Bianca Klabbers, Mark Lubberink, Ronald Boellaard, Marieke D. Spreeuwenberg, Ben J. Slotman, Remco de Bree, Egbert F. Smit, Otto S. Hoekstra & Adriaan A. Lammertsma. (2008) Reproducibility of quantitative 18F-3′-deoxy-3′-fluorothymidine measurements using positron emission tomography. European Journal of Nuclear Medicine and Molecular Imaging 36:3, pages 389-395.
Crossref
Sridhar Nimmagadda & Anthony F. Shields. (2008) The role of DNA synthesis imaging in cancer in the era of targeted therapeutics. Cancer and Metastasis Reviews 27:4, pages 575-587.
Crossref
Nicolas Graf, Ken Herrmann, Jürgen den Hollander, Falko Fend, Tibor Schuster, Hans-Jürgen Wester, Reingard Senekowitsch-Schmidtke, Christian Meyer zum Büschenfelde, Christian Peschel, Markus Schwaiger, Tobias Dechow & Andreas K. Buck. (2008) Imaging Proliferation to Monitor Early Response of Lymphoma to Cytotoxic Treatment. Molecular Imaging and Biology 10:6, pages 349-355.
Crossref
. (2008) Current Awareness in Hematological Oncology. Hematological Oncology 26:1, pages 46-53.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.